Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SBC
SBC logo

SBC Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
4.155
Open
4.150
VWAP
4.14
Vol
3.82K
Mkt Cap
425.69M
Low
4.120
Amount
15.84K
EV/EBITDA(TTM)
4.56
Total Shares
102.58M
EV
319.71M
EV/OCF(TTM)
12.96
P/S(TTM)
2.46
SBC Medical Group Holdings Incorporated is a management company, which owns, operates, and provides management services to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including, but not limited to, advertising and marketing needs across various platforms, staff management, booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumable's procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program, and payment tools for the franchisee clinics.
Show More

Events Timeline

(ET)
2026-03-27
16:30:00
Major Averages Drop Due to Strait of Hormuz Incidents
select
2026-03-27
12:00:00
Major Averages Decline Amid Middle East Tensions
select
2026-03-27
06:50:00
SBC Medical Q4 Revenue at $40M, Below Consensus
select
2026-03-27
06:50:00
SBC Medical Reports 11% Increase in Average Revenue per Customer in Q4
select
2026-03-24 (ET)
2026-03-24
08:20:00
SBC Medical Group Launches SBC Wellness 2.0 Platform
select
2026-01-07 (ET)
2026-01-07
09:40:00
OrangeTwist Forms Strategic Alliance with SBC Medical Group Holdings
select

News

Globenewswire
8.5
03-31Globenewswire
SBC Medical Group's Global Expansion Strategy
  • Revenue Growth Signal: SBC Medical Group reported an 11% year-over-year increase in average revenue per visit to $316 in Q4 2025, indicating a recovery after several quarters of compression, which enhances investor confidence in the company's financial health.
  • U.S. Market Expansion: The minority investment in OrangeTwist marks SBC Medical's official entry into the U.S. market, a crucial step in its global expansion strategy that is expected to enhance brand visibility and increase market share.
  • High-Profit Business Model: With over 40% EBITDA margins across a network of 283 locations and 6.63 million annual patient visits, SBC Medical's capital-light business model demonstrates effectiveness, providing robust support for future expansion initiatives.
  • Strong Financial Position: The company boasts $164 million in cash and low leverage, offering flexibility for M&A and continued expansion, which supports its SBC Wellness 2.0 initiative in Japan's $34 billion longevity market.
Newsfilter
8.5
03-31Newsfilter
SBC Medical Group's Global Expansion Strategy
  • Revenue Growth Signal: SBC Medical Group's average revenue per visit increased by 11% year-over-year to $316 in Q4, indicating a recovery in unit economics after several quarters of compression, which suggests potential improvements in future profitability.
  • U.S. Market Expansion: By making a minority investment in OrangeTwist, SBC Medical officially enters the U.S. market, a strategic move that not only broadens its global business footprint but also lays the groundwork for its presence in the competitive U.S. aesthetic market.
  • Efficient Business Model: The company has achieved EBITDA margins exceeding 40% across a network of 283 locations, demonstrating the success of its capital-light business model while catering to 6.63 million annual patient visits, thus ensuring operational efficiency.
  • Long-term Growth Plans: SBC Medical aims to leverage AI-driven operational infrastructure and expand SBC Wellness 2.0 into Japan's $34 billion longevity market, showcasing its forward-looking strategy in the global healthcare services sector.
seekingalpha
9.5
03-27seekingalpha
SBC Medical Group Q4 Earnings Beat Expectations
  • Earnings Beat: SBC Medical Group reported a Q4 GAAP EPS of $0.14, exceeding expectations by $0.03, indicating resilience in profitability despite overall revenue decline.
  • Revenue Decline: The fourth-quarter revenue of $39.57 million represents a 10.9% year-over-year decrease, missing expectations and reflecting the impact of intensified market competition and fluctuating customer demand.
  • Significant EBITDA Drop: The company's EBITDA stood at $14 million, a 35% year-over-year decline, with an EBITDA margin of 34%, down 12 percentage points from the previous year, highlighting challenges in cost control and operational efficiency.
  • Customer Growth and Buyback Plan: As of December 31, 2025, SBC Medical Group had 6.6 million customers, a 12% year-over-year increase, while announcing a $20 million share repurchase program aimed at enhancing shareholder value and boosting market confidence.
moomoo
9.5
03-27moomoo
SBC Medical Group Holdings Inc. Reports 11% Year-Over-Year Decline in Q4 Total Revenues, Reaching $40 Million
  • Revenue Decline: Medical Group Holdings reported a 11% decrease in total revenues year-over-year, amounting to $40 million.
  • Financial Performance: The decline in revenue indicates potential challenges faced by the company in maintaining its financial performance compared to the previous year.
moomoo
9.5
03-27moomoo
SBC Medical Group Holdings Inc. Reports 133% Year-Over-Year Increase in Q4 EPS to $0.14
  • Earnings Growth: Medical Group Holdings reported a 133% increase in earnings per share (EPS) year-over-year, reaching $0.14.
  • Financial Performance: The significant rise in EPS indicates strong financial performance and growth for the company in the fourth quarter.
Newsfilter
8.5
03-16Newsfilter
SBC Medical Group Opens Flagship Store in Tokyo
  • Global Expansion Strategy: SBC Medical Group is set to open its flagship 'NEO Skin Clinic' in Tokyo's Ginza district on March 28, 2026, which will not only enhance its competitiveness in the global medical tourism market but also solidify its market position in Japan.
  • Multi-Brand Strategy Implementation: By offering dedicated VIP rooms for high-end clients at the Ginza flagship, SBC Medical leverages its network of 283 affiliated clinics, expected to diversify revenue streams and improve profitability to meet evolving market demands.
  • Integration of Technology and Innovation: NEO Skin Clinic will utilize the VISIA skin diagnostic system, combining clinical insights from Japan and South Korea to ensure scientifically precise treatment plans, thereby enhancing customer satisfaction and strengthening brand trust.
  • Future Development Plans: SBC Medical Group aims to further expand into the Nagoya and Kobe areas by the end of 2026, targeting sustainable growth and long-term enhancement of corporate value in response to the growing global interest in non-invasive treatments.
Wall Street analysts forecast SBC stock price to rise
1 Analyst Rating
Wall Street analysts forecast SBC stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
9.00
Averages
9.00
High
9.00
Current: 0.000
sliders
Low
9.00
Averages
9.00
High
9.00
BTIG
Sam Eiber
initiated
$8
AI Analysis
2026-03-06
Reason
BTIG
Sam Eiber
Price Target
$8
AI Analysis
2026-03-06
initiated
Reason
BTIG analyst Sam Eiber initiated coverage of SBC Medical Group with a Buy rating and $8 price target. SBC is the leading aesthetic medical group in Japan with more than 250 franchises and over 6.5M annual patient visits, the analyst tells investors in a research note. The firm says the shares represent an opportunity for investors looking to own an outside of the U.S. business that has "numerous growth prospects" and is trading at a discount to peers.
Maxim
Maxim
initiated
$9
2025-11-05
Reason
Maxim
Maxim
Price Target
$9
2025-11-05
initiated
Reason
Maxim initiated coverage of SBC Medical Group with a Buy rating and $9 price target.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for SBC
Unlock Now

Valuation Metrics

The current forward P/E ratio for SBC Medical Group Holdings Inc (SBC.O) is 8.94, compared to its 5-year average forward P/E of 4.17. For a more detailed relative valuation and DCF analysis to assess SBC Medical Group Holdings Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
4.17
Current PE
8.94
Overvalued PE
8.26
Undervalued PE
0.08

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.62
Current EV/EBITDA
4.73
Overvalued EV/EBITDA
2.00
Undervalued EV/EBITDA
-0.76

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.25
Current PS
2.17
Overvalued PS
2.43
Undervalued PS
0.07

Financials

AI Analysis
Annual
Quarterly

Whales Holding SBC

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is SBC Medical Group Holdings Inc (SBC) stock price today?

The current price of SBC is 4.155 USD — it has increased 0.12

What is SBC Medical Group Holdings Inc (SBC)'s business?

SBC Medical Group Holdings Incorporated is a management company, which owns, operates, and provides management services to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including, but not limited to, advertising and marketing needs across various platforms, staff management, booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumable's procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program, and payment tools for the franchisee clinics.

What is the price predicton of SBC Stock?

Wall Street analysts forecast SBC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SBC is9.00 USD with a low forecast of 9.00 USD and a high forecast of 9.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is SBC Medical Group Holdings Inc (SBC)'s revenue for the last quarter?

SBC Medical Group Holdings Inc revenue for the last quarter amounts to 39.57M USD, decreased -10.93

What is SBC Medical Group Holdings Inc (SBC)'s earnings per share (EPS) for the last quarter?

SBC Medical Group Holdings Inc. EPS for the last quarter amounts to 0.14 USD, increased 133.33

How many employees does SBC Medical Group Holdings Inc (SBC). have?

SBC Medical Group Holdings Inc (SBC) has 863 emplpoyees as of April 13 2026.

What is SBC Medical Group Holdings Inc (SBC) market cap?

Today SBC has the market capitalization of 425.69M USD.